Skip to main content
Top
Published in: Respiratory Research 1/2008

Open Access 01-12-2008 | Research

Effects of intranasal TNFα on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis

Authors: Henrik Widegren, Jonas Erjefält, Magnus Korsgren, Morgan Andersson, Lennart Greiff

Published in: Respiratory Research | Issue 1/2008

Login to get access

Abstract

Background

TNFα may contribute to the pathophysiology of airway inflammation. For example, we have recently shown that nasal administration of TNFα produces late phase co-appearance of granulocyte and plasma exudation markers on the mucosal surface. The objective of the present study was to examine indices of granulocyte presence and activity in response to intranasal TNFα challenge.

Methods

Healthy subjects and patients with allergic rhinitis (examined out of season) were subjected to nasal challenge with TNFα (10 μg) in a sham-controlled and crossover design. Nasal lavages were carried out prior to and 24 hours post challenge. Nasal biopsies were obtained post challenge. Nasal lavage fluid levels of myeloperoxidase (MPO) and eosinophil cationic protein (ECP) were analyzed as indices of neutrophil and eosinophil activity. Moreover, IL-8 and α2-macroglobulin were analyzed as markers of pro-inflammatory cytokine production and plasma exudation. Nasal biopsy numbers of neutrophils and eosinophils were monitored.

Results

Nasal lavage fluid levels of MPO recorded 24 hours post TNFα challenge were increased in healthy subjects (p = 0.0081) and in patients with allergic rhinitis (p = 0.0081) (c.f. sham challenge). Similarly, α2-macroglobulin was increased in healthy subjects (p = 0.014) and in patients with allergic rhinitis (p = 0.0034). Lavage fluid levels of ECP and IL-8 were not affected by TNFα challenge. TNFα increased the numbers of subepithelial neutrophils (p = 0.0021), but not the numbers of eosinophils.

Conclusion

TNFα produces a nasal inflammatory response in humans that is characterised by late phase (i.e., 24 hours post challenge) neutrophil activity and plasma exudation.
Literature
1.
2.
go back to reference Gosset P, Tsicopoulos A, Wallaert B, Joseph M, Capron A, Tonnel AB: Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am Rev Respir Dis 1992,146(3):768–774.CrossRefPubMed Gosset P, Tsicopoulos A, Wallaert B, Joseph M, Capron A, Tonnel AB: Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am Rev Respir Dis 1992,146(3):768–774.CrossRefPubMed
3.
go back to reference Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DT, Gordon JR, Dvorak AM, Weller PF, Galli SJ: Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993,91(6):2673–2684.CrossRefPubMedPubMedCentral Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DT, Gordon JR, Dvorak AM, Weller PF, Galli SJ: Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993,91(6):2673–2684.CrossRefPubMedPubMedCentral
4.
go back to reference Finotto S, Ohno I, Marshall JS, Gauldie J, Denburg JA, Dolovich J, Clark DA, Jordana M: TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994,153(5):2278–2289.PubMed Finotto S, Ohno I, Marshall JS, Gauldie J, Denburg JA, Dolovich J, Clark DA, Jordana M: TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994,153(5):2278–2289.PubMed
5.
go back to reference Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S: Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994,105(3):687–696.CrossRefPubMed Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S: Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994,105(3):687–696.CrossRefPubMed
6.
go back to reference Devalia JL, Campbell AM, Sapsford RJ, Rusznak C, Quint D, Godard P, Bousquet J, Davies RJ: Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993,9(3):271–278.CrossRefPubMed Devalia JL, Campbell AM, Sapsford RJ, Rusznak C, Quint D, Godard P, Bousquet J, Davies RJ: Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993,9(3):271–278.CrossRefPubMed
7.
go back to reference Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994,10(5):471–480.CrossRefPubMed Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994,10(5):471–480.CrossRefPubMed
8.
go back to reference Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990,346(6281):274–276.CrossRefPubMed Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990,346(6281):274–276.CrossRefPubMed
10.
go back to reference Thomas PS, Yates DH, Barnes PJ: Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995,152(1):76–80.CrossRefPubMed Thomas PS, Yates DH, Barnes PJ: Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995,152(1):76–80.CrossRefPubMed
11.
go back to reference Howarth PH, Babu KS, Arshad HS, Lau LC, Buckley MG, McConnell W, Beckett P, Ali MA, Chauhan A, Wilson SJ, et al.: Tumour Necrosis Factor (TNF{alpha}) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax 2005. Howarth PH, Babu KS, Arshad HS, Lau LC, Buckley MG, McConnell W, Beckett P, Ali MA, Chauhan A, Wilson SJ, et al.: Tumour Necrosis Factor (TNF{alpha}) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax 2005.
12.
go back to reference Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID: Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006,354(7):697–708.CrossRefPubMed Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID: Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006,354(7):697–708.CrossRefPubMed
13.
go back to reference Bensch GW, Nelson HS, Borish LC: Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. Ann Allergy Asthma Immunol 2002,88(5):457–462.CrossRefPubMedPubMedCentral Bensch GW, Nelson HS, Borish LC: Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. Ann Allergy Asthma Immunol 2002,88(5):457–462.CrossRefPubMedPubMedCentral
14.
go back to reference Bradding P, Mediwake R, Feather IH, Madden J, Church MK, Holgate ST, Howarth PH: TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995,25(5):406–415.CrossRefPubMed Bradding P, Mediwake R, Feather IH, Madden J, Church MK, Holgate ST, Howarth PH: TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995,25(5):406–415.CrossRefPubMed
15.
go back to reference Ying S, Robinson DS, Varney V, Meng Q, Tsicopoulos A, Moqbel R, Durham SR, Kay AB, Hamid Q: TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy 1991,21(6):745–750.CrossRefPubMed Ying S, Robinson DS, Varney V, Meng Q, Tsicopoulos A, Moqbel R, Durham SR, Kay AB, Hamid Q: TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy 1991,21(6):745–750.CrossRefPubMed
16.
go back to reference Widegren H, Korsgren M, Andersson M, Greiff L: Effects of TNFalpha on the human nasal mucosa in vivo. Respir Med 2007,101(9):1982–1987.CrossRefPubMed Widegren H, Korsgren M, Andersson M, Greiff L: Effects of TNFalpha on the human nasal mucosa in vivo. Respir Med 2007,101(9):1982–1987.CrossRefPubMed
17.
go back to reference Persson CG, Erjefalt JS, Greiff L, Andersson M, Erjefalt I, Godfrey RW, Korsgren M, Linden M, Sundler F, Svensson C: Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J 1998,11(4):958–970.CrossRefPubMed Persson CG, Erjefalt JS, Greiff L, Andersson M, Erjefalt I, Godfrey RW, Korsgren M, Linden M, Sundler F, Svensson C: Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J 1998,11(4):958–970.CrossRefPubMed
18.
go back to reference Greiff L, Pipkorn U, Alkner U, Persson CG: The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990,20(3):253–259.CrossRefPubMed Greiff L, Pipkorn U, Alkner U, Persson CG: The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990,20(3):253–259.CrossRefPubMed
19.
go back to reference Svensson C, Andersson M, Persson CG, Venge P, Alkner U, Pipkorn U: Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990,85(5):828–833.CrossRefPubMed Svensson C, Andersson M, Persson CG, Venge P, Alkner U, Pipkorn U: Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990,85(5):828–833.CrossRefPubMed
20.
go back to reference Akerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CG: Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol 1993,113(5):642–648.CrossRefPubMed Akerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CG: Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol 1993,113(5):642–648.CrossRefPubMed
21.
go back to reference Corne JM, Lau L, Scott SJ, Davies R, Johnston SL, Howarth PH: The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. Am J Respir Crit Care Med 2001,163(5):1101–1107.CrossRefPubMed Corne JM, Lau L, Scott SJ, Davies R, Johnston SL, Howarth PH: The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. Am J Respir Crit Care Med 2001,163(5):1101–1107.CrossRefPubMed
22.
go back to reference Klemens C, Rasp G, Jund F, Hilgert E, Devens C, Pfrogner E, Kramer MF: Mediators and cytokines in allergic and viral-triggered rhinitis. Allergy Asthma Proc 2007,28(4):434–441.CrossRefPubMed Klemens C, Rasp G, Jund F, Hilgert E, Devens C, Pfrogner E, Kramer MF: Mediators and cytokines in allergic and viral-triggered rhinitis. Allergy Asthma Proc 2007,28(4):434–441.CrossRefPubMed
23.
go back to reference Kyan-Aung U, Haskard DO, Poston RN, Thornhill MH, Lee TH: Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991,146(2):521–528.PubMed Kyan-Aung U, Haskard DO, Poston RN, Thornhill MH, Lee TH: Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991,146(2):521–528.PubMed
24.
go back to reference Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr: Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 1985,135(3):2069–2073.PubMed Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr: Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 1985,135(3):2069–2073.PubMed
25.
go back to reference He J, Wang T, Yao L, Chen A, Zhou B, Yu H, Jia R, Cheng C, Huan L, Zhang Z: Construction and delivery of gene therapy vector containing soluble TNFalpha receptor-IgGFc fusion gene for the treatment of allergic rhinitis. Cytokine 2006,36(5–6):296–304.CrossRefPubMed He J, Wang T, Yao L, Chen A, Zhou B, Yu H, Jia R, Cheng C, Huan L, Zhang Z: Construction and delivery of gene therapy vector containing soluble TNFalpha receptor-IgGFc fusion gene for the treatment of allergic rhinitis. Cytokine 2006,36(5–6):296–304.CrossRefPubMed
Metadata
Title
Effects of intranasal TNFα on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis
Authors
Henrik Widegren
Jonas Erjefält
Magnus Korsgren
Morgan Andersson
Lennart Greiff
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2008
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-9-15

Other articles of this Issue 1/2008

Respiratory Research 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine